IMRAN TRIMZI: Open Payments
NPI 1467502773 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$199 in 8 payments from 6 companies in 2025. Trend: 2023 $162 · 2024 $449 · 2025 $199
Food & beverage: $199
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $65 |
| Neurocrine BioSciences, Inc. | 2 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Alkermes, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, Auvelity, LYBALVI, REXULTI.
Industry payments across DE — which companies pay providers there.
